Sort   by:  
 Page size 
UnknownPanel sequencing of 264 candidate susceptibility genes and segregation analysis in a cohort of non-BRCA1, non-BRCA2 breast cancer families.
Not available
S-EPMC6238949 | biostudies-literature
UnknownBreast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2.
Not available
S-EPMC3387216 | biostudies-literature
UnknownComparative microRNA profiling of sporadic and BRCA1 associated basal-like breast cancers.
Not available
S-EPMC4494690 | biostudies-literature
UnknownWhole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers.
Not available
S-EPMC6637375 | biostudies-literature
UnknownDNA methylome of familial breast cancer identifies distinct profiles defined by mutation status.
Not available
S-EPMC2833389 | biostudies-literature
UnknownCommon breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.
Not available
S-EPMC3326552 | biostudies-literature
UnknownTargeted RNA-seq successfully identifies normal and pathogenic splicing events in breast/ovarian cancer susceptibility and Lynch syndrome genes.
Not available
S-EPMC6635756 | biostudies-literature
UnknownA nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers.
Not available
S-EPMC3415567 | biostudies-literature
UnknownThe TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Not available
S-EPMC2768437 | biostudies-literature
UnknownMendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers.
Not available
S-EPMC6738050 | biostudies-literature
Sort   by:  
 Page size